South Korean medical AI company Lunit has recently secured deals with hospitals in Europe, where the medical device market – the second largest after the North American market – is worth $155 billion.
It won the contract to supply a lung disease screening solution to TeleDiag, the largest teleradiology group in France.
Lunit was also chosen to provide a mammography analysis solution to the...
AI-driven dermatology platform Cureskin has netted $20 million in a Series B funding round led by HealthQuad. The round was also participated by JSW Ventures, Khosla Ventures, and Sharrp Ventures.
"These funds will help further enhance our AI capabilities, accelerate our growth, and expand solution offerings," said co-founder and CEO Guna Kakulapati in a statement.
Cureskin previously raised $5...
The health technology segment in India, which comprises about 10,000 startups, is projected to triple in value by 2028 as investors shift their focus towards businesses that can withstand economic disruptions.
A new report by global management consultant Bain & Company, in collaboration with Indian healthcare-focused venture fund HealthQuad, delved into the local healthcare innovation market...
Indian medical imaging AI company InMed AI has released a new AI-powered tool for screening traumatic brain injuries (TBI).
The Neuroshield CT TBI is a decision support tool for detecting and quantifying intracranial haemorrhage, fracture, and midline shift. Utilising AI, it automatically processes brain CT images and alerts clinicians of critical findings.
Commenting on the technology, Dr...
India-based healthcare and life sciences technology provider and consultant CitiusTech has claimed to come up with what could be the industry's first generative AI quality and trust solution.
Based on a press statement, the CitiusTech Gen AI Quality & Trust solution aims to help with the design, development, integration, monitoring of, and facilitating quality and trust in genAI applications...
Rural-focused e-clinics chain CureBay scored another Rs 620 million ($7.5 million) in funding as part of a Series A round led by Elevar Equity. This comes on top of the first $6 million it raised in 2022.
According to their press release, the additional funds will be used to invest in their membership programme by hiring over 200 data scientists and experts in pharmacy and diagnostics. It will...
Samsung to integrate Lunit's AI in premium X-ray devices
South Korean medical AI provider Lunit has signed a three-year supply contract with Samsung Electronics.
The deal is for the integration of Lunit's two chest X-ray AI solutions – Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage – into Samsung's line of premium X-ray devices.
According to a press release, the AI-integrated X-ray devices will...
New player in digital diabetes management
Diabetes app Smit.fit from India and Qatar-based digital therapeutics (DTx) company Droobi Health have announced their merger.
The combined entity called DroobiSmit, headquartered in Singapore, aims to be a leading diabetes solution provider in the Middle East and South Asia regions. It will offer personalised solutions for people with pre-diabetes,...
Meds tracking live on Samsung Health
Samsung Electronics has started rolling out a new Medications tracking feature on the Samsung Health app to help users manage their medications and improve adherence.
The feature helps users keep track of their prescription and over-the-counter medications. It also provides users detailed information about their medications, including potential side effects...
Indian AI drug discovery firm gets $1M to focus on rare diseases
Peptris Technologies from Bangalore, India has received $1 million in pre-seed funding in a round led by Speciale Invest.
In a statement, the AI-driven drug discovery company said it will use its fresh funds to expand its research scope to cover rare diseases, adding to its existing work in cancer and inflammation.
Cipla raises...
